Literature DB >> 10914341

Mortality among three refinery/petrochemical plant cohorts. II. Retirees.

J F Gamble1, R J Lewis, G Jorgensen.   

Abstract

This study updates mortality data for 6238 retirees from three refinery/petrochemical plants. Almost 90% of the cohort was deceased. Deaths from all causes (standardized mortality ratio, 104; 95% confidence interval, 102 to 107) and all cancers (standardized mortality ratio, 109; 95% confidence interval, 102 to 116) were elevated. Increased deaths due to kidney cancer, mesothelioma, and the category of other lymphohemopoietic cancers also were observed. The rate of leukemia was not increased. There was little internal or external consistency to support an occupational relationship for kidney cancer, but findings for mesothelioma and other lymphohemopoietic cancers are consistent with reports for other petroleum cohorts. Analyses by age indicated significantly higher all-cause mortality rates among persons retiring before age 65. The results suggest that continued surveillance of mesothelioma and lymphohemopoietic cancer malignancies in younger workers with more contemporary exposures may be warranted. Furthermore, age at retirement should be considered when analyzing occupational cohorts.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10914341     DOI: 10.1097/00043764-200007000-00008

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  2 in total

Review 1.  Cancer Incidence and Mortality among Petroleum Industry Workers and Residents Living in Oil Producing Communities: A Systematic Review and Meta-Analysis.

Authors:  Felix M Onyije; Bayan Hosseini; Kayo Togawa; Joachim Schüz; Ann Olsson
Journal:  Int J Environ Res Public Health       Date:  2021-04-20       Impact factor: 3.390

2.  Lymphohematopoietic cancer mortality and morbidity of workers in a refinery/petrochemical complex in Korea.

Authors:  Dong-Hee Koh; Tae-Woo Kim; Yong-Hoon Yoon; Kyung-Seok Shin; Seung-Won Yoo
Journal:  Saf Health Work       Date:  2011-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.